BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17452932)

  • 1. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.
    Rodríguez A; Mendia A; Sirvent JM; Barcenilla F; de la Torre-Prados MV; Solé-Violán J; Rello J;
    Crit Care Med; 2007 Jun; 35(6):1493-8. PubMed ID: 17452932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
    Blot S; Depuydt P
    Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study.
    Moine P; Timsit JF; De Lassence A; Troché G; Fosse JP; Alberti C; Cohen Y;
    Intensive Care Med; 2002 Feb; 28(2):154-63. PubMed ID: 11907658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
    Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
    J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
    Tessmer A; Welte T; Martus P; Schnoor M; Marre R; Suttorp N
    J Antimicrob Chemother; 2009 May; 63(5):1025-33. PubMed ID: 19293196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy.
    Corona A; Wilson AP; Grassi M; Singer M
    J Antimicrob Chemother; 2004 Oct; 54(4):809-17. PubMed ID: 15375106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.
    Gowardman J; Trent L
    N Z Med J; 2000 May; 113(1109):161-4. PubMed ID: 10894342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Community acquired pneumococcal pneumonia in hospitalized adult patients].
    Díaz A; Torres C; Flores LJ; García P; Saldías F
    Rev Med Chil; 2003 May; 131(5):505-14. PubMed ID: 12879811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis.
    Paul M; Nielsen AD; Gafter-Gvili A; Tacconelli E; Andreassen S; Almanasreh N; Goldberg E; Cauda R; Frank U; Leibovici L
    Eur Respir J; 2007 Sep; 30(3):525-31. PubMed ID: 17537772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.
    Choudhury G; Mandal P; Singanayagam A; Akram AR; Chalmers JD; Hill AT
    Clin Microbiol Infect; 2011 Dec; 17(12):1852-8. PubMed ID: 21919994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.